People with urinary tract infections, especially those involving the bladder or kidneys, may be prescribed Cipro XR. This antibiotic works by interfering with the process that bacteria need to multiply. It comes in tablet form and is usually taken once a day. Most people tolerate it well, but side effects can include nausea, vomiting, and diarrhea.
What Is Cipro XR?
Cipro® XR (ciprofloxacin extended release) is a prescription medication that belongs to a group of drugs called fluoroquinolones, or "quinolones" for short. Like other quinolones, Cipro XR is an antibiotic. It is approved to treat urinary tract infections, including bladder and kidney infections.
Cipro XR is made by Bayer HealthCare Pharmaceuticals, Inc. It is distributed by Schering Corporation.
How Does It Work?
Cipro XR works to treat infections by killing the bacteria that cause them. Specifically, Cipro XR interferes with two bacterial enzymes: topoisomerase IV and DNA gyrase. These enzymes are necessary for the bacteria to copy and repair DNA, which are critical steps needed for the bacteria to multiply.
In clinical studies, Cipro XR was shown to treat bladder infections (cystitis) and kidney infections (pyelonephritis) as well as short-acting Cipro® (ciprofloxacin). For example, in one study, 95 percent of people were successfully treated for cystitis after three days of receiving Cipro XR, compared to almost 92 percent of people given regular Cipro for three days.
Micromedex Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed October 27, 2010.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed October 27, 2010.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed October 27, 2010.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 28, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click